Relatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomics
Open Access
Abstract
Ten medically important Saccharomyces strains, comprising six clinical isolates of Saccharomyces cerevisiae and four probiotic strains of Saccharomyces boulardii, were characterized at the genetic and metabolic level and compared with non‐medical, commercial yeast strains used in baking and wine‐making. Strains were compared by genetic fingerprinting using amplified fragment length polymorphism (AFLP) analysis, by ribosomal DNA ITS1 sequencing and by metabolic footprinting using both direct injection mass spectrometry (DIMS) and gas chromatography–time of flight–mass spectrometry (GC–ToF–MS). Overall, the clinical isolates fell into different groupings when compared with the non‐medical strains, with good but not perfect correlation amongst strains at both the genetic and metabolic levels. Probiotic strains of S. boulardii that are used therapeutically to treat human gastro‐intestinal tract disorders showed tight clustering both genetically and metabolically. Metabolomics was found to be of value both as a taxonomic tool and as a means to investigate anomalous links between genotype and phenotype. Key discriminatory metabolites were identified when comparing the three main groups of clinical, probiotic and non‐medical strains and included molecules such as trehalose, myo‐inositol, lactic acid, fumaric acid and glycerol 3‐phosphate. This study confirmed the link between a subset of clinical isolates and baking or probiotic strains but also highlighted that in general the clinical strains were more diverse at both the genomic and metabolic levels. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 51 references indexed in Scilit:
- Role of 14-3-3 proteins in the regulation of neutral trehalase in the yeastSaccharomyces cerevisiaeFEMS Yeast Research, 2008
- Genotypic and Physiological Characterization of Saccharomyces boulardii , the Probiotic Strain of Saccharomyces cerevisiaeApplied and Environmental Microbiology, 2007
- Molecular Monitoring of the Fecal Microbiota of Healthy Human Subjects during Administration of Lactulose and Saccharomyces boulardiiApplied and Environmental Microbiology, 2006
- A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factorsAntonie van Leeuwenhoek, 2006
- Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expressionBiochemical and Biophysical Research Communications, 2006
- Metabolic footprinting and systems biology: the medium is the messageNature Reviews Microbiology, 2005
- Molecular and physiological comparisons betweenSaccharomyces cerevisiaeandSaccharomyces boulardiiCanadian Journal of Microbiology, 2004
- A Saccharomyces gene family involved in invasive growth, cell–cell adhesion, and matingProceedings of the National Academy of Sciences, 2000
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952